LAP (Latency Associated peptide) Monoclonal Antibody (TW7-16B4), PE-Cyanine7, eBioscience™, Invitrogen™

Description

• Description: The TW7-16B4 monoclonal antibody reacts with mouse latency associated peptide (LAP, pro-TGF beta 1, LAP/TGF beta 1)
• Many different cells produce TGF beta and it mediates effects on the proliferation, differentiation and function of many cell types
• TGF beta is synthesized as a precursor that contains LAP at the N-terminus and mature TGF beta at the C-terminus
• Processing and cleavage of the precursor protein between amino acids 278 and 279 results in the formation of LAP dimers and TGF beta dimers that then non-covalently associate with each other to form the small latent TGF beta complex
• LAP is secreted and can be found in the extracellular matrix
• In addition, LAP can also be expressed on platelets and activated regulatory T cells
• It is believed that this surface-expressed LAP is due to the binding of LAP to GARP (LRRC32), which is a transmembrane protein that is also found at high levels on platelets and activated regulatory T cells
• Applications Reported: This TW7-16B4 antibody has been reported for use in flow cytometric analysis
• Applications Tested: This TW7-16B4 antibody has been tested by flow cytometric analysis of stimulated mouse splenocytes
• This can be used at less than or equal to 0.125 μg per test
• A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
• Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
• LAP (Latency Associated peptide) Monoclonal antibody specifically detects LAP (Latency Associated peptide) in Mouse samples
• It is validated for Flow Cytometry.